中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
32期
59-60,62
,共3页
罗显荣%侯丽%张静%何刚
囉顯榮%侯麗%張靜%何剛
라현영%후려%장정%하강
西替利嗪%布地奈德%支气管哮喘%变应性鼻炎
西替利嗪%佈地奈德%支氣管哮喘%變應性鼻炎
서체리진%포지내덕%지기관효천%변응성비염
Cetirizine%Budesonide%Bronchial asthma%Allergic rhinitis
目的:探讨西替利嗪滴剂联合雾化布地奈德混悬液治疗儿童支气管哮喘合并变应性鼻炎的临床疗效。方法:2012年3月-2014年4月收治支气管哮喘合并变应性鼻炎患儿58例,随机分为两组,各29例,两组在相同对症支持治疗的基础上,治疗组给予口服西替利嗪滴剂,3~6岁2.5 mg/次,2次/d,>6岁5 mg/次,2次/d,雾化吸入布地奈德混悬液2 mL,2次/d;对照组同法给予雾化吸入布地奈德混悬液,同时口服氯雷他定5~10 mg,1次/d,每晚睡前服,疗程均为2个月。观察两组患儿治疗后的鼻塞、喷嚏、流涕、咳嗽、喘息等改善情况。结果:治疗组鼻炎治疗总有效率89.7%,对照组总有效率58.6%。治疗组鼻塞、喷嚏、流涕等鼻炎症状改善优于对照组,两组比较差异具有统计学意义(P<0.05);治疗组哮喘治疗总有效率93.1%,对照组总有效率65.5%,治疗组咳嗽、喘息症状改善优于对照组,两组比较差异具有统计学意义(P<0.05)。结论:西替利嗪滴剂联合雾化布地奈德治疗儿童支气管哮喘合并变应性鼻炎具有良好的临床疗效与安全性,依从性好,不良反应少。
目的:探討西替利嗪滴劑聯閤霧化佈地奈德混懸液治療兒童支氣管哮喘閤併變應性鼻炎的臨床療效。方法:2012年3月-2014年4月收治支氣管哮喘閤併變應性鼻炎患兒58例,隨機分為兩組,各29例,兩組在相同對癥支持治療的基礎上,治療組給予口服西替利嗪滴劑,3~6歲2.5 mg/次,2次/d,>6歲5 mg/次,2次/d,霧化吸入佈地奈德混懸液2 mL,2次/d;對照組同法給予霧化吸入佈地奈德混懸液,同時口服氯雷他定5~10 mg,1次/d,每晚睡前服,療程均為2箇月。觀察兩組患兒治療後的鼻塞、噴嚏、流涕、咳嗽、喘息等改善情況。結果:治療組鼻炎治療總有效率89.7%,對照組總有效率58.6%。治療組鼻塞、噴嚏、流涕等鼻炎癥狀改善優于對照組,兩組比較差異具有統計學意義(P<0.05);治療組哮喘治療總有效率93.1%,對照組總有效率65.5%,治療組咳嗽、喘息癥狀改善優于對照組,兩組比較差異具有統計學意義(P<0.05)。結論:西替利嗪滴劑聯閤霧化佈地奈德治療兒童支氣管哮喘閤併變應性鼻炎具有良好的臨床療效與安全性,依從性好,不良反應少。
목적:탐토서체리진적제연합무화포지내덕혼현액치료인동지기관효천합병변응성비염적림상료효。방법:2012년3월-2014년4월수치지기관효천합병변응성비염환인58례,수궤분위량조,각29례,량조재상동대증지지치료적기출상,치료조급여구복서체리진적제,3~6세2.5 mg/차,2차/d,>6세5 mg/차,2차/d,무화흡입포지내덕혼현액2 mL,2차/d;대조조동법급여무화흡입포지내덕혼현액,동시구복록뢰타정5~10 mg,1차/d,매만수전복,료정균위2개월。관찰량조환인치료후적비새、분체、류체、해수、천식등개선정황。결과:치료조비염치료총유효솔89.7%,대조조총유효솔58.6%。치료조비새、분체、류체등비염증상개선우우대조조,량조비교차이구유통계학의의(P<0.05);치료조효천치료총유효솔93.1%,대조조총유효솔65.5%,치료조해수、천식증상개선우우대조조,량조비교차이구유통계학의의(P<0.05)。결론:서체리진적제연합무화포지내덕치료인동지기관효천합병변응성비염구유량호적림상료효여안전성,의종성호,불량반응소。
Objective:To investigate the clinical efficacy of cetirizine drops combined with nebulized budesonide suspension in the treatment of children with bronchial asthma complicated with allergic rhinitis.Methods:58 children with bronchial asthma complicated with allergic rhinitis were selected from 2012 March to April 2014.They were randomly divided into two groups with 29 cases in each.Patients in both of the groups were given the same basic treatment.Moreover,the treatment group were given oral cetirizine drops,2.5 mg every time for 3~6 years old children,2 times/d;for children who was more than 6 years old,they were given 5 mg every time,2 times/d,inhalation of budesonide suspension in 2 mL,2 times/d.The control group were given budesonide atomization inhalation with the same methods above,and also given 5~10 mg oral loratadine at the same time,1 time/d at every night before bedtime,the course of treatment both were 2 months.Then we observed the improvement in sneezing,runny nose,stuffy nose,cough,wheezing of two groups after treatment.Results:The total effectiveness of rhinitis in the treatment group was 89.7%,and that in the control group was 58.6%.The improvement of nasal congestion,sneezing,runny nose and other symptoms of rhinitis in the treatment group was better than that in the control group,and the differences were statistically significant between the two groups(P<0.05).The total effectiveness of asthma in the treatment group was 93.1%,and that in the control group was 65.5%.The improvement in cough and wheezing symptoms of the treatment group were better than the control group,and the differences were statistically significant between the two groups(P<0.05).Conclusion:Cetirizine drops combined with nebulized budesonide in the treatment of children with bronchial asthma complicated with allergic rhinitis has good clinical efficacy.It is safe and has good compliance.It also has less adverse reaction.